Elevance Health (ELV) Change in Acquisitions & Divestments (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $552.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 30.19% year-over-year to $552.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 billion (down 0.78% YoY) and the FY2025 annual result came in at $1.8 billion, down 12.54% from the prior year.
• Change in Acquisitions & Divestments fell to $552.0 million in Q1 2026 per ELV's latest filing, from $576.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $7.1 billion in Q2 2023 and bottomed at -$11.6 billion in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $552.0 million (2026), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments jumped 215.27%; it then sank 484.57% in 2023.
• Tracing ELV's Change in Acquisitions & Divestments over 5 years: stood at $3.0 billion in 2022, then slumped by 484.57% to -$11.6 billion in 2023, then surged by 104.69% to $544.0 million in 2024, then increased by 5.88% to $576.0 million in 2025, then slipped by 4.17% to $552.0 million in 2026.
• Per Business Quant, the three latest ELV Change in Acquisitions & Divestments figures stand at $552.0 million (Q1 2026), $576.0 million (Q4 2025), and $447.0 million (Q3 2025).

Peer Comparison